Duy Nguyen

USPTO Granted Patents = 29 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 15 (Patent Applications = 20)

Average Co-Inventor Count = 8.5

ph-index = 6

Forward Citations = 86(Granted Patents)

Company Filing History:

14 out of 378

Bayer Pharma Aktiengesellschaft

patents

7 out of 192

Bayer Schering Pharma Ag

patents

6 out of 443

The Broad Institute, Inc.

The General Hospital Corporation

patents

6. 5 out of 12,157

Bayer Aktiengesellschaft

patents

7. 3 out of 1,384

Schering Aktiengesellschaft

patents

8. 3 out of 721

Bayer Intellectual Property Gmbh

patents

9. 1 out of 1

Bayer Pharma Aktiengellschaft

patent

10. 1 out of 5

Bayer Aktiengellschaft

patents

11. 1 out of 1

Bayer Pharma Aktiegellschaft

patent

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

29 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12486248 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2025-12-02),

2. 11787797 - 4,5-annulated 1,2,4-triazolones (2023-10-17),

3. 11713304 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2023-08-01),

4. 11130745 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2021-09-28),

5. 10968216 - 4,5-annulated 1,2,4-triazolones (2021-04-06),

6. 10919862 - Fused imidazoles as mIDH1 inhibitors (2021-02-16),

7. 10815215 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2020-10-27),

8. 10442772 - Benzimidazol-2-amines as mIDH1 inhibitors (2019-10-15),

9. 10137110 - 1-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumors (2018-11-27),

10. 9957235 - Benzimidazol-2-amines as mIDH1 inhibitors (2018-05-01),

11. 9951027 - Benzimidazol-2-amines as MIDH1 inhibitors (2018-04-24),

12. 9468642 - Imidazopyrazines (2016-10-18),

13. 9428460 - [object Object] (2016-08-30),

14. 9388140 - Substituted benzimidazoles (2016-07-12),

15. 9340528 - Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors (2016-05-17),

Title: Inventor Duy Nguyen: Revolutionizing Technology in Berlin

Introduction: Duy Nguyen is a visionary inventor based in Berlin, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Duy Nguyen holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, Duy Nguyen has led numerous successful projects that have pushed the boundaries of technological advancement. His innovative solutions have garnered recognition both locally and internationally.

Collaborations: Throughout his career, Duy Nguyen has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work across disciplines has led to the development of cutting-edge technologies that have the potential to shape the future.

Conclusion: Duy Nguyen's relentless pursuit of innovation and his dedication to creating impactful solutions have solidified his position as a prominent figure in the world of technology. His work continues to inspire and drive progress in the ever-evolving field of invention.

This text is generated by artificial intelligence and may not be accurate.